ArticleReumatologia clinica2021

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab.

Luis Figuero-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.